Journals / Türk Toraks Dergisi / 2011 / Cilt: 12 - Sayı: 3

The diagnostic value of oxidative stress products in pulmonary embolism

Pulmoner embolide oksidatif stres ürünlerinin tanısal değeri

Pages
100–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We need more studies about using IMA levels as an indicator for diagnosis of pulmonary embolism. (Tur Toraks Der 2011; 12: 100-4)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study is to show the oxidative stress in pulmonary embolism by detecting the levels of ischemia modified albumin (IMA), advanced oxidation protein product (AOPP) and malondialdehyde (MDA) in patients with pulmonary embolism.
📊
Key Findings & Data:Material and Method: 39 patients, who were dagnosed with pulmonary embolism in the Emergency Service or Thoracic Diseases Polyclinic of the Trakya University Faculty of Medicine between September 1, 2008 and March 31, 2009, and 39 healthy volunteers were included in the study.
💡
Conclusion & Impact:We need more studies about using IMA levels as an indicator for diagnosis of pulmonary embolism. (Tur Toraks Der 2011; 12: 100-4)
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of our study is to show the oxidative stress in pulmonary embolism by detecting the levels of ischemia modified albumin (IMA), advanced oxidation protein product (AOPP) and malondialdehyde (MDA) in patients with pulmonary embolism. Material and Method: 39 patients, who were dagnosed with pulmonary embolism in the Emergency Service or Thoracic Diseases Polyclinic of the Trakya University Faculty of Medicine between September 1, 2008 and March 31, 2009, and 39 healthy volunteers were included in the study. IMA, AOPP and MDA levels were studied. T-test and Mann Whitney and X2 tests were applied in independent samples. A value of p<0.05 was accepted as statistically significant. Results: There was no significant difference between the two groups in terms of age, height, and weight. The difference in the AOPP levels of the two groups was not significant. The difference in the serum albumin levels of the two groups was found significant (p<0.001). The difference in levels of IMA after being corrected according to the albumin levels of the two groups was not significant. MDA levels of the two groups showed a significant difference (p=0.032). Conclusion: AOPP levels in patients with pulmonary embolism were not found different but, the increases of MDA levels were significant. We suggest using albumin-adjusted IMA levels to interpret IMA levels more correctly. We need more studies about using IMA levels as an indicator for diagnosis of pulmonary embolism. (Tur Toraks Der 2011; 12: 100-4)

Özet

Amaç: Bu çalışmada, pulmoner embolili hastalarda oksidatif stres ürünleri olan iskemi modifiye albumin (IMA), ileri oksidasyon protein ürünü (AOPP) ve malondialdehit (MDA) düzeylerini belirleyerek pulmoner embolideki oksidatif stresin gösterilmesi amaçlanmıştır. Gereç ve Yöntem: Çalışmaya 01 Eylül 2008 ile 31 Mart 2009 tarihleri arasında Trakya Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Polikliniği veya Acil Servisinde pulmoner emboli tanısı alan 39 hasta ve 39 sağlıklı gönüllü dahil edildi. Hastalardan alınan kanlarda IMA, AOPP ve MDA düzeyleri çalışıldı. Bağımsız örneklerde t testi, Mann Whitney ve X2 testleri uygulandı. p<0.05 değerleri istatistiksel olarak anlamlı kabul edildi. Bulgular: Her iki grubun yaş, boy, kilo özellikleri karşılaştırıldığında gruplar arasında anlamlı fark saptanmadı. İki grup arasında AOPP seviyeleri arasında anlamlı bir fark saptanmadı. Serum albumin düzeyleri embolili grupta düşük olarak saptandı (p<0.001). IMA’nın albumine göre düzeltildikten sonraki değerleri her iki grup arasında benzer olarak tespit edildi. Emboli grubunda MDA düzeyleri sağlıklı grup ile karşılaştırıldığında anlamlı olarak yüksek tespit edildi (p=0.032). Sonuç: AOPP düzeyleri embolili hastalarda farklı saptanmaz iken MDA düzeylerindeki yükselme anlamlı idi. IMA değerlerinin doğru yorumlanabilmesi için albumine göre düzeltilmiş IMA değerlerinin kullanılmasının daha doğru olacağı düşüncesindeyiz. IMA’nın emboli tanısında bir belirteç olarak kullanılması ile ilgili yeni çalışmalara ihtiyaç vardır. (Tur Toraks Der 2011; 12: 100-4)

🔖

Cite This Article

BATMAZ, E., EDİS, E. Ç., ESKİOCAK, S., HATİPOĞLU, O. N., KAYA, S. (2011). The diagnostic value of oxidative stress products in pulmonary embolism. Türk Toraks Dergisi, Cilt: 12 - Sayı: 3, 100–104. https://ajindex.com/articles/329542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000
  2. [CrossRef] 2. Bulkey GB. The role of oxygen free radicals in human disease process. Surgery 1983
  3. Muhl D, Furedi R, Cristofari J, et al. Evaluation of oxidative stress in the thrombolysis of pulmonary embolism. J Thromb Thrombolysis 2006
  4. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997
  5. Valdez LB, Lores Arnaiz S, Bustamante J, Alvarez S, Costa LE, Boveris A. Free radical chemistry in biological systems. Biol Res 2000
  6. [CrossRef] 6. Kayalı R, Cakatay U. Basic mechanisms of protein oxidation. Cerrahpaşa J Med 2004
  7. Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 1988
  8. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia a preliminary report. J Emerg Med 2000
  9. [CrossRef] 9. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001
  10. [CrossRef] 10. Turedi S, Gunduz A, Mentese A, et al. Value of ischemiamodified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007
  11. [CrossRef] 11. Turedi S, Gunduz A, Mentese A, et al. The value of ischemia-modified albumin compared with D-dimer in the diagnosis of pulmonary embolism. Respir Res 2008
  12. [CrossRef] 12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979
  13. [CrossRef] 13. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996
  14. [CrossRef] 14. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992
  15. [CrossRef] 15. Perrier A. Noninvasive diagnosis of pulmonary embolism. Haematologica 1997
  16. [CrossRef] 16. Brown MD, Lau J, Nelson RD, Kline JA. In the diagnosis of pulmonary embolism: a metaanalysis. Clin Chem 2003
  17. [CrossRef] 17. Brown MD, Rowe BH, Reeves MJ, Bermingh